Cargando…
Temporary Vitelliform Regression After Intravitreal Ranibizumab Injection for Macular Neovascularization Complicating Best Disease
BACKGROUND: In this report, we present a case of a 12-year-old boy with Best vitelliform macular dystrophy (BVMD) complicated by macular neovascularization (MNV) and treated with two intravitreal ranibizumab injections. We document an unusual temporary regression of his vitelliform deposits and desc...
Autor principal: | Fayed, Alaa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587723/ https://www.ncbi.nlm.nih.gov/pubmed/36281445 http://dx.doi.org/10.2147/IMCRJ.S383541 |
Ejemplares similares
-
Intravitreal bevacizumab in choroidal neovascularization associated with Best's vitelliform dystrophy
por: Mandal, Subrata, et al.
Publicado: (2011) -
Choroidal Neovascularization Associated with Best Vitelliform Macular Dystrophy
por: Adiyeke, Seda Karaca, et al.
Publicado: (2022) -
Intravitreal bevacizumab for choroidal neovascular membrane associated with Best's vitelliform dystrophy
por: Rishi, Ekta, et al.
Publicado: (2010) -
Multimodal Imaging Characteristics of Quiescent Type 1 Neovascularization in Best Vitelliform Macular Dystrophy
por: Menteş, Jale, et al.
Publicado: (2021) -
Choroidal neovascularization secondary to Best’s vitelliform macular dystrophy in two siblings of a Malay family
por: Alisa-Victoria, Koh, et al.
Publicado: (2014)